NCT05361655View on ClinicalTrials.gov

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

CompletedOBSERVATIONAL

Enrollment

2,888

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Palbociclib + an aromatase inhibitor

Palbociclib + an aromatase inhibitor therapy

DRUG

Aromatase inhibitor

Aromatase inhibitor therapy

Trial Locations (1)

10017

10017, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05361655 - Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor | Biotech Hunter | Biotech Hunter